PRDM16-DT and lung adenocarcinoma: LINC00982 also has reduced expression levels in lung adenocarcinoma compared to non‐tumor tissue35 and also in RCC,36 which agrees with our results, indicating that LINC00982 could be a potential diagnostic biomarker of RCC.